• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[低剂量吲哚美辛与普瑞巴林联合治疗持续性偏头疼成功:病例报告]

[Successful treatment of hemicrania continua with a combination of low-dose indomethacin and pregabalin: a case report].

作者信息

Kikui Shoji, Miyahara Jun-ichi, Kashiwaya Yoshihiro, Takeshima Takao

机构信息

Department of Neurology, Tominaga Hospital.

出版信息

Rinsho Shinkeigaku. 2014;54(10):824-6. doi: 10.5692/clinicalneurol.54.824.

DOI:10.5692/clinicalneurol.54.824
PMID:25342018
Abstract

A 51-year-old man complained of continuous pain lasting about 3 weeks around his forehead and left orbit-locations where pain may indicate conjunctival injection and lacrimation. Upon arrival to our hospital, his neurological examination was normal, and brain MRI showed no abnormality. The headache disappeared with indomethacin treatment (75 mg/day), and a diagnosis of hemicrania continua (HC) was established according to the International Classification of Headache Disorders, 2nd Edition. The headache returned after reducing the dose of indomethacin. After adding pregabalin (150 mg/day) to his treatment regimen, we could reduce the dose of indomethacin from 75 mg/day to 25 mg/day, which the patient tolerated well. Although HC is one of the indomethacin-responsive headaches, continuous administration can cause side effects including gastrointestinal disorders. Such side effects can decrease the tolerability of indomethacin, and may eventually lead to its reduction or discontinuation. Pregabalin can be an alternative to indomethacin for treating HC.

摘要

一名51岁男性主诉前额和左眼眶周围持续疼痛约3周,疼痛部位可能出现结膜充血和流泪。入院时,他的神经系统检查正常,脑部MRI未显示异常。使用吲哚美辛治疗(75毫克/天)后头痛消失,根据《国际头痛疾病分类》第二版,确诊为持续性偏侧头痛(HC)。减少吲哚美辛剂量后头痛复发。在治疗方案中加用普瑞巴林(150毫克/天)后,我们能够将吲哚美辛剂量从75毫克/天减至25毫克/天,患者耐受性良好。虽然HC是对吲哚美辛有反应的头痛之一,但持续用药会引起包括胃肠道疾病在内的副作用。这些副作用会降低对吲哚美辛的耐受性,并最终可能导致其减量或停药。普瑞巴林可作为治疗HC的吲哚美辛替代药物。

相似文献

1
[Successful treatment of hemicrania continua with a combination of low-dose indomethacin and pregabalin: a case report].[低剂量吲哚美辛与普瑞巴林联合治疗持续性偏头疼成功:病例报告]
Rinsho Shinkeigaku. 2014;54(10):824-6. doi: 10.5692/clinicalneurol.54.824.
2
Melatonin responsive hemicrania continua in which indomethacin was associated with contralateral headache.伴有吲哚美辛相关性对侧头痛的褪黑素反应性连续性头痛
Headache. 2014 May;54(5):916-9. doi: 10.1111/head.12270. Epub 2013 Nov 21.
3
Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua.
Cephalalgia. 2001 Nov;21(9):906-10. doi: 10.1046/j.1468-2982.2001.00287.x.
4
Indomethacin-induced de novo headache in hemicrania continua--fighting fire with fire?消炎痛诱导的慢性偏头痛新发头痛——以毒攻毒?
Cephalalgia. 2013 Oct;33(14):1203-5. doi: 10.1177/0333102413490345. Epub 2013 May 24.
5
A case report: indomethacin resistance hemicrania continua or a new entity?
Agri. 2014;26(3):138-40. doi: 10.5505/agri.2014.41713.
6
Can indomethacin act as a disease modifying agent in hemicrania continua? A supportive clinical case.吲哚美辛能否作为持续性偏头疼的病情缓解剂?一则支持性临床病例。
Headache. 2009 May;49(5):759-61. doi: 10.1111/j.1526-4610.2009.01407.x.
7
A case of remitting hemicrania continua with seasonal variation and clustering: a diagnostic confusion with cluster headache.一例伴有季节性变化和发作丛集性的缓解型持续性偏侧头痛:与丛集性头痛的诊断混淆
BMJ Case Rep. 2019 May 19;12(5):e229650. doi: 10.1136/bcr-2019-229650.
8
Hemicrania continua: Indomethacin induced myoclonus.
Clin Neurol Neurosurg. 2021 Jul;206:106703. doi: 10.1016/j.clineuro.2021.106703. Epub 2021 May 20.
9
[Hemicrania continua: the first Japanese case report].
Rinsho Shinkeigaku. 2002 Aug;42(8):754-6.
10
Chronic paroxysmal hemicrania and hemicrania continua. Parenteral indomethacin: the 'indotest'.慢性发作性偏侧头痛和持续性偏侧头痛。胃肠外吲哚美辛:“吲哚美辛试验”
Headache. 1998 Feb;38(2):122-8. doi: 10.1046/j.1526-4610.1998.3802122.x.